AUSTIN, Texas, Oct. 20, 2026 /PRNewswire/ — Phantom Neuro today announced that the first participants with upper limb loss in its CYBORG early feasibility study have undergone implantation of Phantom X, a device placed under the skin in one’s residual limb, turning muscle signals into wireless commands for a prosthetic limb. The procedures were performed at Cabrini Health in Melbourne, Australia.
The implantations mark the first time Phantom Neuro’s sensor has been implanted in human participants. The initial participants were implanted during outpatient procedures lasting roughly an hour each, without the use of general anesthesia, providing a strong signal for the simplicity and safety of Phantom X implantation. CYBORG is an ongoing study evaluating the safety, performance and usability of Phantom X in people with upper-limb loss.